SCOTTSDALE, ARIZONA, January 9, 2020 – Healthcare Trust of America,
Inc. (NYSE:HTA or the “Company”), announced today that its Board of Directors
has appointed Mr. H. Lee Cooper and Mr. Jay P. Leupp as new Independent
Directors of the Board. In addition, the Company announced the resignation of
current director Mr. Daniel S. Henson.
Mr. Cooper is a distinguished
leader in the healthcare industry, including roles in healthcare-focused
private equity and more than 25 years with the General Electric Company (“GE”).
Mr. Cooper is currently an operating partner at Welsh, Carson, Anderson &
Stowe where he focuses on healthcare investing. Prior to that time, Mr. Cooper
served as a long-time executive at GE, most recently as the President & CEO
of GE Healthcare Systems, U.S. and Canada, until his recent retirement from GE.
In this role, he oversaw GE Healthcare’s core businesses of Imaging,
Ultrasound, Life Care Solutions, Enterprise Digital Solutions and Services and
partnered with care providers, healthcare systems and governments to improve
healthcare quality, access and affordability.
Mr. Leupp is a long-time REIT
veteran, with over 25 years in the publicly-traded real estate markets. Mr.
Leupp is currently the Managing Director, Senior Portfolio Manager for Lazard
Asset Management LLC in San Francisco, CA where he has worked since 2011. Prior
to that time, Mr. Leupp had a long career as a REIT equity analyst, including
as a managing director at RBC and Robertson Stephens. Mr. Leupp also holds an
MBA degree from Harvard University and a Bachelor’s degree in accounting from
Santa Clara University. He currently serves on the Board of Directors of G.W.
Williams Company, San Francisco Catholic Charities, and on the Policy Board of
the Fisher Center for Real Estate at the University of California, Berkeley.
Additionally, HTA announced today
that Daniel S. Henson will be resigning from his current board seat, effective
January 8, 2020 to focus on his board chair roles for portfolio companies affiliated
with the Blackstone Companies. Mr. Henson has been a valued member of the HTA Board
of Directors since 2016 and was most recently the chairperson for the Company’s
Risk Management Committee and a member of the Company’s Investment Committee.
“We are proud to welcome Lee and Jay
to our team. Lee brings to the Company a distinguished Fortune 500 public
company background, healthcare experience and relationships, and leadership
skills; Jay has extensive and broad real estate, financial, and capital markets
expertise and has held several board of director and leadership positions,”
stated Founder, Chairman and CEO Scott D. Peters. “We believe the addition of
these two individuals will continue to position us as the leading provider of
medical office buildings and allow us to continue to produce attractive returns
for our stockholders. We also want to thank Dan for his contributions and
guidance during his tenure with the Board.”
With the appointment of Mr. Cooper and
Mr. Leupp and departure of Mr. Henson, HTA’s board membership will increase to
ten total individuals on the Board of Directors until the 2020 Annual Meeting
of Stockholders. HTA also expects that the newly appointed directors will be
nominated for re-election at the Annual Meeting in July 2020.
The Board has determined that Mr. Cooper
and Mr. Leupp have no material interests in any transactions with the Company
and both qualify as independent directors under the applicable New York Stock
Exchange, and the Securities and Exchange Commission requirements.
Healthcare Trust of America, Inc.
(NYSE: HTA) is the largest dedicated owner and operator of medical office
buildings in the United States, comprising approximately 23.7 million square
feet of GLA, with $7.0 billion invested primarily in medical office buildings
as of September 30, 2019. HTA provides
real estate infrastructure for the integrated delivery of healthcare services
in highly-desirable locations.
Investments are targeted to build critical mass in 20 to 25 leading
gateway markets that generally have leading university and medical institutions
which translates to superior demographics, high-quality graduates, intellectual
talent and job growth. The strategic
markets HTA invests in support a strong, long-term demand for quality medical
office space. HTA utilizes an integrated
asset management platform consisting of on-site leasing, property management,
engineering and building services, and development capabilities to create
complete, state of the art facilities in each market. This drives efficiencies, strong tenant and
health system relationships, and strategic partnerships that result in high
levels of tenant retention, rental growth and long-term value creation. Headquartered in Scottsdale, Arizona, HTA has
developed a national brand with dedicated relationships at the local level.
Founded in 2006
and listed on the New York Stock Exchange in 2012, HTA has produced attractive
returns for its stockholders that have outperformed the S&P 500 and US REIT
index. More information about HTA can be
found on the Company’s Website (www.htareit.com), Facebook, LinkedIn and
This press release contains certain
Forward-looking statements are based on current expectations, plans,
estimates, assumptions and beliefs, including expectations, plans, estimates,
assumptions and beliefs about HTA, stockholder value and earnings growth.
The forward-looking statements
included in this press release are subject to numerous risks and uncertainties
that could cause actual results to differ materially from those expressed or
implied in the forward-looking statements.
Assumptions relating to the foregoing involve judgments with respect to,
among other things, future economic, competitive and market conditions and
future business decisions, all of which are difficult or impossible to predict
accurately and many of which are beyond HTA’s control. Although HTA believes that the expectations
reflected in such forward-looking statements are based on reasonable
assumptions, HTA’s actual results and performance could differ materially and
in adverse ways from those set forth in the forward-looking statements. Factors which could have a material adverse
effect on HTA’s operations and future prospects include, but are not limited
Forward-looking statements speak only as of the date
made. Except as otherwise required by
the federal securities laws, HTA undertakes no obligation to update any
forward-looking statements to reflect the events or circumstances arising after
the date as of which they are made. As a
result of these risks and uncertainties, readers are cautioned not to place
undue reliance on the forward-looking statements included in this press release
or that may be made elsewhere from time to time by, or on behalf of, HTA.